Skip to main content

Table 3 Lipid testing in the past 5 years for adults with low cardiovascular disease (CVD) risk (<10 %) by number of CVD risk factors

From: Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study

Row(%)

No risk factors

1-4 risk factors

 

Lipid tests

Lipid tests

a) Men

Age

0

1

2

3+

Total

0

1

2

3+

Total

25-34

64.2

27.4

6.4

2.0

891

60.3

26.3

8.5

4.9

763

35-44

41.6

40.2

11.6

6.6

2040

45.3

35.2

11.7

7.9

1438

45-54

29.3

43.3

18.0

9.4

1853

31.3

39.9

15.5

13.4

479

55-64

25.5

40.1

23.4

10.9

192

0.0

50.0

25.0

25.0

4

65-79

0.0

0.0

100.0

0.0

1

    

0

Total

40.4

39.0

13.5

7.0

4977

47.0

33.5

11.5

8.0

2684

b) Women

Age

0

1

2

3+

Total

0

1

2

3+

Total

25-34

74.8

19.6

3.4

2.2

2017

62.3

25.5

7.2

5.0

1242

35-44

50.6

35.0

10.1

4.3

3730

42.1

35.4

13.6

8.9

2706

45-54

29.9

43.4

18.4

8.3

4708

28.1

38.1

20.7

13.1

3285

55-64

22.4

40.4

22.1

15.2

3869

22.5

34.8

25.3

17.5

1616

65-79

20.4

37.2

24.4

18.0

861

18.4

26.6

32.3

22.8

158

Total

38.5

37.1

15.6

8.8

15,185

35.9

34.8

17.7

11.7

9007

  1. Risk factors include diabetes, treated hypertension, current smoker, body mass index >30. Yellow shading indicates more testing than recommended by the United States Preventive Services Task Force (USPSTF) for persons with no risk factors. Green shading indicates less testing than recommended for persons with one or more risk factors and who are not already on statins. Cross-hatch lines signify risk categories with no study subjects